A detailed history of Black Rock Inc. transactions in Pro Phase Labs, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 64,299 shares of PRPH stock, worth $39,222. This represents 0.0% of its overall portfolio holdings.

Number of Shares
64,299
Previous 57,361 12.1%
Holding current value
$39,222
Previous $371,000 27.76%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$4.18 - $7.35 $29,000 - $50,994
6,938 Added 12.1%
64,299 $268,000
Q1 2024

May 10, 2024

SELL
$4.47 - $6.47 $15,166 - $21,952
-3,393 Reduced 5.58%
57,361 $371,000
Q4 2023

Feb 13, 2024

BUY
$4.35 - $5.1 $6,785 - $7,955
1,560 Added 2.64%
60,754 $274,000
Q3 2023

Nov 13, 2023

SELL
$4.23 - $7.53 $111,574 - $198,618
-26,377 Reduced 30.82%
59,194 $258,000
Q2 2023

Aug 11, 2023

SELL
$7.15 - $9.78 $155,305 - $212,431
-21,721 Reduced 20.24%
85,571 $621,000
Q1 2023

May 12, 2023

SELL
$6.62 - $9.57 $167,035 - $241,470
-25,232 Reduced 19.04%
107,292 $817,000
Q4 2022

Feb 13, 2023

BUY
$8.78 - $12.47 $3,371 - $4,788
384 Added 0.29%
132,524 $1.28 Million
Q3 2022

Nov 14, 2022

BUY
$8.96 - $14.7 $883,294 - $1.45 Million
98,582 Added 293.77%
132,140 $1.49 Million
Q2 2022

Aug 12, 2022

BUY
$6.52 - $13.24 $50,451 - $102,451
7,738 Added 29.97%
33,558 $425,000
Q1 2022

May 12, 2022

SELL
$6.2 - $7.87 $5,511 - $6,996
-889 Reduced 3.33%
25,820 $180,000
Q4 2021

Feb 10, 2022

SELL
$5.13 - $7.89 $10,613 - $16,324
-2,069 Reduced 7.19%
26,709 $191,000
Q3 2021

Nov 09, 2021

BUY
$4.89 - $7.82 $17,833 - $28,519
3,647 Added 14.51%
28,778 $150,000
Q2 2021

Aug 11, 2021

BUY
$4.61 - $6.83 $115,853 - $171,644
25,131 New
25,131 $156,000

Others Institutions Holding PRPH

About ProPhase Labs, Inc.


  • Ticker PRPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 16,024,400
  • Market Cap $9.77M
  • Description
  • ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...
More about PRPH
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.